Drug Profile
Cabazitaxel cellulose nanoparticle - Triphase Accelerator Corporation
Alternative Names: CBZed-Nano™Latest Information Update: 28 May 2020
Price :
$50
*
At a glance
- Originator Triphase Accelerator Corporation
- Class Antineoplastics; Taxanes
- Mechanism of Action Tubulin inhibitors; Tubulin polymerisation promoters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Glioma; Prostate cancer
Most Recent Events
- 28 May 2020 No recent reports of development identified for preclinical development in Glioma in Canada (Parenteral, Injection)
- 28 May 2020 No recent reports of development identified for preclinical development in Glioma in USA (Parenteral, Injection)
- 28 May 2020 No recent reports of development identified for preclinical development in Prostate-cancer in Canada (Parenteral, Injection)